CMB.TECH nv CMBT
19.01
(0.03)
(0.16%)
as of 25 Sep
- Market cap
- $5.5B
- P/E
- 3.9×
Follow CMBT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | 2.62 | — |
P/S ratio |
— | — | 1.73 | — | |
P/FCF ratio |
— | — | 5.80 | — | |
P/Operating CF |
— | — | 21.93 | — | |
P/B ratio |
— | — | 1.25 | — | |
Price to Tangible BV |
— | — | 1.34 | — | |
EV/Sales |
— | — | 4.02 | — | |
EV/EBITDA |
— | — | 6.30 | — | |
EV/Operating CF |
— | — | 18.56 | — | |
EV/FCF |
— | — | 13.44 | — | |
Quick Ratio |
0.50 | 0.44 | 0.67 | 0.70 | |
Current Ratio |
0.73 | 0.86 | 0.95 | 1.12 | |
Net Debt/EBITDA |
0.00 | 0.00 | 11.01 | 0.00 | |
Debt/Assets |
64.72% | 63.59% | 59.63% | 59.44% | |
Debt/Equity |
2.12 | 2.04 | 1.71 | 1.68 | |
Asset Turnover |
0.00 | 0.00 | 0.25 | 0.00 | |
Operating CF/Net income |
0.00 | — | 0.45 | 0.00 | |
Capex/Depreciation |
(1.65) | — | — | (0.12) | |
Interest Coverage |
— | — | 0.00 | — | |
Research and Development Expense of Revenue |
— | — | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
— | — | 3.44% | — | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
— | — | 0.00% | — | |
Graham Net Nets |
— | — | (1.29) | — | |
Graham Number |
— | — | 33.19 | — | |
Earnings Yield |
— | — | 38.18% | — | |
Free Cash Flow Yield |
— | — | 17.24% | — | |
Revenue per Share |
— | — | 2.78 | — | |
Operating CF per Share |
0.00 | — | 0.58 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 0.58 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.70 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 10.14 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 10.14 | 0.00 | |
Free Cash Flow |
(234.18) | — | 167.35 | 224.75 | |
Working Capital |
(225.75) | (148.26) | (44.05) | 99.79 | |
Capital Expenditures |
(450.07) | — | — | (25.19) | |
Net Current Asset Value |
(5,220.47) | (4,869.70) | (4,738.25) | (4,787.87) | |
EV/EBIT |
— | — | 6.78 | — | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
— | — | 45.69% | — | |
Price to Operating Income |
— | — | 2.93 | — | |
| Other line items | |||||
Average Receivables |
304.23 | 278.36 | 374.92 | 419.29 | |
Average Payables |
153.44 | 151.04 | 230.73 | 213.52 | |
Average Inventory |
62.52 | 51.84 | 67.16 | 89.51 | |
Average Assets |
5,994.81 | 6,155.31 | 8,343.96 | 8,613.63 | |
Average Common Equity |
1,824.83 | 1,907.82 | 2,782.12 | 2,836.92 |
Columns are period end dates